======= NOSIP ======= == Gene Information == * **Official Symbol**: NOSIP * **Official Name**: nitric oxide synthase interacting protein * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51070|51070]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y314|Q9Y314]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NOSIP&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NOSIP|Open PubMed]] * **OMIM**: [[https://omim.org/entry/616759|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: E3 ubiquitin-protein ligase that is essential for proper development of the forebrain, the eye, and the face. Catalyzes monoubiquitination of serine/threonine-protein phosphatase 2A (PP2A) catalytic subunit PPP2CA/PPP2CB (By similarity). Negatively regulates nitric oxide production by inducing NOS1 and NOS3 translocation to actin cytoskeleton and inhibiting their enzymatic activity (PubMed:11149895, PubMed:15548660, PubMed:16135813). {ECO:0000250|UniProtKB:Q9D6T0, ECO:0000269|PubMed:11149895, ECO:0000269|PubMed:15548660, ECO:0000269|PubMed:16135813}. |Rtf2| |negative regulation of nitric-oxide synthase activity| |negative regulation of monooxygenase activity| |negative regulation of oxidoreductase activity| |regulation of nitric-oxide synthase activity| |regulation of monooxygenase activity| |regulation of oxidoreductase activity| |ubiquitin protein ligase activity| |Golgi membrane| |protein ubiquitination| |protein modification by small protein conjugation| |negative regulation of catalytic activity| |protein modification by small protein conjugation or removal| |negative regulation of molecular function| |RNA binding| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-2.76| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-2.6| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.33| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|-2.17| |[[:results:exp432|YM155 0.001μM R08 exp432]]|-2.03| |[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|-1.98| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-1.97| |[[:results:exp222|Betulinic acid 10 to 15μM on day4 R05 exp222]]|-1.95| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|-1.94| |[[:results:exp436|Dynasore 7μM R08 exp436]]|-1.91| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|-1.88| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|-1.83| |[[:results:exp473|Cincreasin 100μM R08 exp473]]|-1.81| |[[:results:exp210|LB-100 2μM R05 exp210]]|-1.76| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|-1.74| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|-1.72| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|1.74| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|1.79| |[[:results:exp518|RK-33 8μM R08 exp518]]|2.14| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|2.34| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|2.39| |[[:results:exp502|Milciclib 2μM R08 exp502]]|2.6| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18038 * **Expression level (log2 read counts)**: 5.61 {{:chemogenomics:nalm6 dist.png?nolink |}}